MedFuture-B Surges as Post-IPO Recovery Continues
MedFuture-B (6132.HK) surged 8% in Hong Kong trading to HK$38.60, with turnover of HK$19.53 million.
The stock reached a high of HK$40.20 today, extending its rebound since listing. It debuted on the Main Board on June 23 at an issue price of HK$81.80, then tumbled more than 57% on its first day to close at HK$35.26, making it the worst-performing new issue this year. Some analysts say investment logic in the HK 18A sector is shifting, with capital prioritizing cash flow and commercial certainty, leading to corrections in high valuation expectations.
Source: HK Stock Market Update The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments